EN
HI
Bliss GVS Pharma Share price
BLISSGVS
519.25
5.25 (1.02%)NSE
BSE
Last updated on 14 Aug, 2026 | 15:31 IST
Bliss GVS Pharma share price chart
Bliss GVS Pharma Share Key Metrics
Volume
3.90 L
Market Cap
5493.09 CR
LTQ@LTP
10@519.25
ATP
519.74
Var Margin
100 %
Circuit Range
493.3-545.2
Delivery %
0 %
Value
20.29 CR
ASM/GSM
No
Market Lot
1
Summary
BLISSGVS stock price is ₹519.25 as of 15 Aug, 2026. The stock intraday movement has stayed between ₹496.10 and ₹530.80, while Bliss GVS Pharma share price 52 week high low is ₹118.00 & ₹553.00.
In terms of trading activity, BLISSGVS share price has recorded a volume of 3,90,435 shares. The Bliss GVS Pharma has a market cap of ₹105788972. The stock’s Average Traded Price (ATP) stands at ₹519.74, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹519.25.
The Bliss GVS Pharma upper circuit limit is ₹545.20 & The Bliss GVS Pharma lower circuit limit is ₹493.30, with a Value of ₹20.29 CR. The Delivery Percentage for the day is 0%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Bliss GVS Pharma Resistance and Support
Pivot 511
Resistance
First Resistance
517
Second Resistance
520
Third Resistance
526
Support
First Support
508
Second Support
502
Third Support
499
Bliss GVS Pharma Shareholding Pattern
View More- 2016-17
- 2017-18
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
35.01%
Mutual Fund
0.26%
Insurance
3.24%
Foreign Institutional Investors
8.07%
Domestic Institutional Investors
5.83%
Retail
47.59%
Others
0%
Total Promoters
MAR '26
35.36%
JUN '26
35.01%
Bliss GVS Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
Bliss GVS Pharma News
Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12, 2026
Bliss GVS Pharma reported Q1 FY27 standalone revenue up 35.6% YoY to ₹221.59 crore, with net profit up 83.4% YoY to ₹38.62 crore. Consolidated revenue grew 37.7% YoY to ₹285.58 crore, net profit up 15.8% YoY to ₹51.37 crore. Board also approved a postal ballot for director appointment.
Aug 12 2026 19:39:30
Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
LIC divested a 2.151% stake in Bliss GVS Pharma via market sale, bringing its total holding down to 2.959%. This significant reduction in institutional holding occurred over a period from 2020 to 2026.
Aug 11 2026 13:24:38
Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 12, 2026
Bliss GVS Pharma's Board of Directors will meet on August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This meeting is crucial for investors awaiting the company's latest quarterly performance.
Aug 05 2026 17:07:21
Bliss GVS Pharma Ltd - 506197 - Pre-Offer Advertisement & Corrigendum to Detailed Public Statement
Bliss GVS Pharma provided an update on the Open Offer by Anupam Rasayan India Limited for up to 26% of its equity shares. The tendering period for the offer is scheduled from July 28, 2026, to August 10, 2026, with consideration payment by August 24, 2026.
Jul 27 2026 17:06:33
Bliss GVS Pharma Ltd - 506197 - Intimation Of Recommendations By The Committee Of Independent Directors ('IDC') Pursuant To Regulation 26(7) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Bliss GVS Pharma's Independent Directors Committee (IDC) has recommended public shareholders consider the open offer by Anupam Rasayan India Limited for acquiring up to 26% of the company's shares. The offer price is Rs. 299 per share, which is lower than the current market price of Rs. 482.50.
Jul 22 2026 19:09:34
Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Clarus Capital I and its Persons Acting in Concert (PACs) acquired 1,84,652 shares of Bliss GVS Pharma through open market transactions. This acquisition increased their aggregate shareholding to 5.13%, crossing the regulatory 5% disclosure threshold.
Jul 22 2026 17:13:18
Bliss GVS Pharma Ltd - 506197 - Letter Of Offer Dated July 18, 2026 Received From SBI Capital Markets Limited
Bliss GVS Pharma received an open offer from Anupam Rasayan India for acquiring a 26% stake at ₹299 per share. This mandatory offer will result in a change of control.
Jul 21 2026 19:50:16
Bliss GVS Pharma Ltd - 506197 - Addendum To Public Announcement And Detailed Public Statement
Bliss GVS Pharma informed about an addendum to the public announcement for its open offer. Mates Visa Consultancy Private Limited has been added as a Person Acting in Concert with the acquirer, Anupam Rasayan India Limited, for the acquisition of 26.00% of Bliss GVS Pharma's equity shares.
Jul 19 2026 19:09:16
Read More
Bliss GVS Pharma Management
| Name | Position |
|---|---|
| Aditi Bhatt | Company Secretary & Compliance Officer |
| Nandkumar chodankar | Chairman |
Bliss GVS Pharma Similar Stocks
Nephrocare Health Services Ltd.
696.70
20.80 (3.08%)
Kovai Medical Center & Hospital Ltd.
6038.50
147.00 (2.50%)
Orchid Pharma Ltd.
1045.65
11.75 (1.14%)
Innova Captab Ltd.
1036.00
-11.50 (1.10%)
FDC Ltd.
354.20
-4.55 (1.27%)
Supriya Lifescience Ltd.
791.65
-21.85 (2.69%)
Artemis Medicare Services Ltd.
314.75
-3.10 (0.98%)
IOL Chemicals And Pharmaceuticals Ltd.
165.58
-0.44 (0.27%)
RPG Life Sciences Ltd.
2782.30
-48.20 (1.70%)
Bliss GVS Pharma FAQs
The Buying Price of Bliss GVS Pharma share is 519.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bliss GVS Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bliss GVS Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bliss GVS Pharma shares is 40.89. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bliss GVS Pharma shares is 4.52. Useful to assess the stock's value relative to its book value.
To assess Bliss GVS Pharma’s valuation compare Sector P/E, P/B which are 63.94 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bliss GVS Pharma is 5493.09 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bliss GVS Pharma share price is 553.00 & 118.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bliss GVS Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in BLISSGVS
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC